AnalystsLuca IssiLuca Issi's Stock Forecasts
AnalystsLuca Issi
Sectors:
Industries:
Analyst Ranking
Top 33%
#1652 out of 5020 analysts
Average Return
+0.67%
Win Rate
46%61 out of 133
Risk vs Reward
Poor
Good
Luca Issi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Uniqure NvQURE | +137.93% | $5.88 | $13.99 | 2024-01-15 - 2025-01-15 | Buy |
Verve Therapeutics IncVERV | +123.05% | $4.99 | $11.13 | 2024-08-09 - 2025-07-25 | Buy |
Uniqure NvQURE | +97.77% | $7.16 | $14.16 | 2024-11-05 - 2025-09-17 | Buy |
Meiragtx Holdings PLCMGTX | +90.05% | $4.22 | $8.02 | 2024-08-12 - 2025-08-12 | Buy |
Ionis Pharmaceuticals IncIONS | +87.12% | $32.69 | $61.17 | 2025-02-19 - 2025-09-17 | Buy |
Luca Issi Analyst Color
Get additional color on Luca Issi's coverage of popular stocks
Luca Issi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ionis Pharmaceuticals IncIONS | 9 | Buy | $80.00 | +30.78% | Maintains | 14 days ago |
Argenx SeARGX | 1 | Buy | $850.00 | +15.75% | Initiates Coverage On | 24 days ago |
Regenxbio IncRGNX | 9 | Buy | $17.00 | +88.26% | Maintains | a month ago |
Intellia Therapeutics IncNTLA | 5 | Buy | $21.00 | +69.22% | Maintains | a month ago |
Ascendis Pharma AASND | 3 | Buy | $230.00 | +15.24% | Maintains | a month ago |
Arrowhead Pharmaceuticals IncARWR | 9 | Buy | $38.00 | +30.45% | Maintains | a month ago |
Crispr Therapeutics AgCRSP | 13 | Hold | $42.00 | -28.90% | Maintains | a month ago |
Fulcrum Therapeutics IncFULC | 1 | Hold | $5.00 | -31.69% | Maintains | 2 months ago |
Dyne Therapeutics IncDYN | 3 | Buy | $23.00 | +74.90% | Maintains | 2 months ago |
Adverum Biotechnologies IncADVM | 8 | Hold | $4.00 | +38.89% | Maintains | 4 months ago |
Allogene Therapeutics IncALLO | 8 | Buy | $10.00 | +784.96% | Reiterates | 4 months ago |
Apellis Pharmaceuticals IncAPLS | 7 | Hold | $18.00 | -22.18% | Maintains | 4 months ago |
Moderna IncMRNA | 17 | Hold | $28.00 | +12.00% | Maintains | 5 months ago |
Lexeo Therapeutics IncLXEO | 5 | Buy | $20.00 | +273.13% | Maintains | 6 months ago |
Alnylam Pharmaceuticals IncALNY | 26 | Buy | $330.00 | -26.95% | Maintains | 6 months ago |
Korro Bio IncKRRO | 7 | Buy | $95.00 | +212.71% | Maintains | 6 months ago |
Sangamo Therapeutics IncSGMO | 6 | Hold | $2.00 | +289.86% | Reiterates | 6 months ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $17.00 | +39.75% | Initiates Coverage On | 6 months ago |
Meiragtx Holdings PLCMGTX | 6 | Buy | $13.00 | +77.35% | Maintains | 6 months ago |
Verve Therapeutics IncVERV | 7 | Buy | $15.00 | +34.77% | Maintains | 6 months ago |
4d Molecular Therapeutics IncFDMT | 7 | Buy | $35.00 | +425.53% | Maintains | 7 months ago |
Beam Therapeutics IncBEAM | 7 | Hold | $26.00 | +15.81% | Maintains | 7 months ago |
Biomarin Pharmaceutical IncBMRN | 12 | Hold | $70.00 | +28.75% | Reiterates | 7 months ago |
Uniqure NvQURE | 6 | Buy | $24.00 | +69.49% | Reiterates | 8 months ago |
Schlumberger LimitedSLB | 1 | Buy | $57.00 | +63.84% | Reiterates | 8 months ago |
Avidity Biosciences IncRNA | 2 | Buy | $67.00 | +67.25% | Reiterates | 8 months ago |
Editas Medicine IncEDIT | 8 | Hold | $4.00 | +47.06% | Maintains | 9 months ago |
Bluebird Bio IncBLUE | 4 | Hold | $80.00 | +1,509.66% | Reiterates | 10 months ago |
Ultragenyx Pharmaceutical IncRARE | 3 | Buy | $77.00 | +168.20% | Reiterates | 10 months ago |
Wave Life Sciences LtdWVE | 5 | Hold | $15.00 | +120.59% | Maintains | a year ago |
Caribou Biosciences IncCRBU | 5 | Buy | $14.00 | N/A | Reiterates | a year ago |
Lenz Therapeutics IncLENZ | 3 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Q32 Bio IncQTTB | 3 | Hold | $54.00 | N/A | Maintains | 3 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $38.25 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.